Cizzle Biotechnology Holdings Plc (LON:CIZ)

Market Cap	6.14M -8.8%
Revenue (ttm)	n/a
Net Income	-1.12M
EPS	-0.00
Shares Out	396.39M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,186
Average Volume	297,162
Open	1.405
Previous Close	1.550
Day's Range	1.400 - 1.430
52-Week Range	0.012 - 1.550
Beta	0.53
RSI	60.32
Earnings Date	Apr 30, 2026

About LON:CIZ

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood test for early lung cancer detection using CIZ1B biomarker technology. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.

• Industry: Biotechnology
• Sector: Healthcare
• Employees: 4
• Stock Exchange: London Stock Exchange
• Ticker Symbol: CIZ